{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:11:00Z","timestamp":1720138260151},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00105-024-05370-3","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T17:02:11Z","timestamp":1718902931000},"page":"539-547","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["P\ufefforphyrien\u00a0\u2013 eine \u00dcbersicht","An overview of porphyrias"],"prefix":"10.1007","volume":"75","author":[{"given":"Hanna","family":"Lindemann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Diehl-Wiesenecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lea","family":"Gerischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Frank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,20]]},"reference":[{"key":"5370_CR1","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13023-023-02768-5","volume":"18","author":"E Diehl-Wiesenecker","year":"2023","unstructured":"Diehl-Wiesenecker\u00a0E, Blaschke\u00a0S, Wohmann\u00a0N et\u00a0al (2023) Detect acute porphyrias in emergency departments (DePorED)\u2014a\u00a0pilot study. Orphanet J Rare Dis 18:146","journal-title":"Orphanet J Rare Dis"},{"key":"5370_CR2","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.3390\/diagnostics11101795","volume":"11","author":"A Erwin","year":"2021","unstructured":"Erwin\u00a0A, Balwani\u00a0M (2021) Porphyrias in the age of targeted therapies. Diagnostics 11:1795","journal-title":"Diagnostics"},{"key":"5370_CR3","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.ymgme.2018.12.008","volume":"128","author":"A Erwin","year":"2019","unstructured":"Erwin\u00a0A, Desnick\u00a0R (2019) Congenital erythropoietic porphyria: recent advances. Mol Genet Metab 128:288\u2013297","journal-title":"Mol Genet Metab"},{"key":"5370_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00105-015-3745-3","volume":"67","author":"J Frank","year":"2016","unstructured":"Frank\u00a0J (2016) Neurocutaneous porphyrias. Hautarzt 67:221\u2013225","journal-title":"Hautarzt"},{"key":"5370_CR5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00105-015-3741-7","volume":"67","author":"J Frank","year":"2016","unstructured":"Frank\u00a0J (2016) Diagnosis of the porphyrias: from A (as in aminolevulinic acid) to Z (as in zinc protoporphyrin). Hautarzt 67:201\u2013206","journal-title":"Hautarzt"},{"key":"5370_CR6","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1159\/000029854","volume":"11","author":"J Frank","year":"1998","unstructured":"Frank\u00a0J, Christiano\u00a0A (1998) Variegate porphyria: past, present and future. Skin Pharmacol Appl Skin Physiol 11:310\u2013320","journal-title":"Skin Pharmacol Appl Skin Physiol"},{"key":"5370_CR7","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.bpg.2010.07.002","volume":"24","author":"J Frank","year":"2010","unstructured":"Frank\u00a0J, Poblete-Gutierrez\u00a0P (2010) Porphyria cutanea tarda\u2014when skin meets liver. Best Pract Res Clin Gastroenterol 24:735\u2013745","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"5370_CR8","first-page":"517","volume":"44","author":"G Goerz","year":"1969","unstructured":"Goerz\u00a0G, Ippen\u00a0H (1969) Bloodletting treatment of protoporphyrinemic actinic dermatitis. Z\u00a0Haut Geschlechtskr 44:517\u2013519","journal-title":"Z Haut Geschlechtskr"},{"key":"5370_CR9","first-page":"253","volume":"14","author":"H Ippen","year":"1977","unstructured":"Ippen\u00a0H (1977) Treatment of porphyria cutanea tarda by phlebotomy. Semin Hematol 14:253\u2013259","journal-title":"Semin Hematol"},{"key":"5370_CR10","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.clinre.2015.05.009","volume":"39","author":"Z Karim","year":"2015","unstructured":"Karim\u00a0Z, Lyoumi\u00a0S, Nicolas\u00a0G et\u00a0al (2015) Porphyrias: a\u00a02015 update. Clin Res Hepatol Gastroenterol 39:412\u2013425","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"5370_CR11","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/S0190-9622(81)70065-3","volume":"4","author":"F Koranda","year":"1981","unstructured":"Koranda\u00a0F (1981) Antimalarials. J\u00a0Am Acad Dermatol 4:650\u2013655","journal-title":"J Am Acad Dermatol"},{"key":"5370_CR12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00105-015-3741-7","volume":"67","author":"V Kurten","year":"2016","unstructured":"Kurten\u00a0V, Neumann\u00a0N, Frank\u00a0J (2016) Diagnosis of the porphyrias: from A (as in aminolevulinic acid) to Z (as in zinc protoporphyrin). Hautarzt 67:201\u2013206","journal-title":"Hautarzt"},{"key":"5370_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/8904_2015_406","volume":"22","author":"E Lang","year":"2015","unstructured":"Lang\u00a0E, Schafer\u00a0M, Schwender\u00a0H et\u00a0al (2015) Occurrence of malignant tumours in the acute hepatic porphyrias. JIMD Rep 22:17\u201322","journal-title":"JIMD Rep"},{"key":"5370_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1056\/NEJMoa1411481","volume":"373","author":"J Langendonk","year":"2015","unstructured":"Langendonk\u00a0J, Balwani\u00a0M, Anderson\u00a0K et\u00a0al (2015) Afamelanotide for erythropoietic protoporphyria. N\u00a0Engl J Med 373:48\u201359","journal-title":"N Engl J Med"},{"key":"5370_CR15","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1097\/HEP.0000000000000546","volume":"79","author":"C Levy","year":"2024","unstructured":"Levy\u00a0C, Dickey\u00a0A, Wang\u00a0B et\u00a0al (2024) Evidence-based consensus guidelines for the diagnosis and management of protoporphyria-related liver dysfunction in erythropoietic protoporphyria and\u00a0X-linked protoporphyria. Hepatology 79:731\u2013743","journal-title":"Hepatology"},{"key":"5370_CR16","first-page":"316","volume":"20","author":"W Muschalek","year":"2022","unstructured":"Muschalek\u00a0W, Hermasch\u00a0M, Poblete-Gutierrez\u00a0P et\u00a0al (2022) The porphyrias. J\u00a0Dtsch Dermatol Ges 20:316\u2013331","journal-title":"J Dtsch Dermatol Ges"},{"key":"5370_CR17","first-page":"149","volume":"78","author":"R Neeleman","year":"2020","unstructured":"Neeleman\u00a0R, Wensink\u00a0D, Wagenmakers\u00a0M et\u00a0al (2020) Diagnostic and therapeutic strategies for porphyrias. Neth J Med 78:149\u2013160","journal-title":"Neth J Med"},{"key":"5370_CR18","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1093\/hmg\/ddi342","volume":"14","author":"C Schmitt","year":"2005","unstructured":"Schmitt\u00a0C, Gouya\u00a0L, Malonova\u00a0E et\u00a0al (2005) Mutations in human CPO gene predict clinical expression of either hepatic hereditary coproporphyria or erythropoietic harderoporphyria. Hum Mol Genet 14:3089\u20133098","journal-title":"Hum Mol Genet"},{"key":"5370_CR19","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.bpg.2010.08.010","volume":"24","author":"M Siegesmund","year":"2010","unstructured":"Siegesmund\u00a0M, van Tuyll van Serooskerken\u00a0AM, Poblete-Gutierrez\u00a0P et\u00a0al (2010) The acute hepatic porphyrias: current status and future challenges. Best Pract Res Clin Gastroenterol 24:593\u2013605","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"5370_CR20","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/bjh.14459","volume":"176","author":"P Stein","year":"2017","unstructured":"Stein\u00a0P, Badminton\u00a0M, Rees\u00a0D (2017) Update review of the acute porphyrias. Br J Haematol 176:527\u2013538","journal-title":"Br J Haematol"},{"key":"5370_CR21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00105-015-3733-7","volume":"67","author":"U Urbanski","year":"2016","unstructured":"Urbanski\u00a0U, Frank\u00a0J, Neumann\u00a0N (2016) Erythropoietic protoporphyria: clinical manifestations, diagnosis and new therapeutic possibilities. Hautarzt 67:211\u2013215","journal-title":"Hautarzt"},{"key":"5370_CR22","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1365-2133.2011.10606.x","volume":"166","author":"A van Tuyll van Serooskerken","year":"2012","unstructured":"van Tuyll van Serooskerken\u00a0A, Drogemoller\u00a0B, Te Velde\u00a0K et\u00a0al (2012) Extended haplotype studies in South African and dutch variegate porphyria families carrying the recurrent p.R59W mutation confirm a\u00a0common ancestry. Br J Dermatol 166:261\u2013265","journal-title":"Br J Dermatol"},{"key":"5370_CR23","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s00105-015-3732-8","volume":"67","author":"C Wenner","year":"2016","unstructured":"Wenner\u00a0C, Neumann\u00a0N, Frank\u00a0J (2016) Congenital erythropoietic porphyria : an update. Hautarzt 67:216\u2013220","journal-title":"Hautarzt"},{"key":"5370_CR24","first-page":"1313","volume":"46","author":"E Darwich","year":"2010","unstructured":"Darwich\u00a0E, To-Figueras\u00a0J, Badenas\u00a0C et\u00a0al (2010) Hepatoerythropoietic porphyria and familial porphyria cutanea tarda in Spanish patients: G281E mutation in the uroporphyrinogen decarboxylase gene. Arch Dermatol 46:1313\u20131314","journal-title":"Arch Dermatol"},{"key":"5370_CR25","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00431-007-0557-1","volume":"167","author":"A Lecluse","year":"2008","unstructured":"Lecluse\u00a0A, Kuck-Koot\u00a0V, van Weelden\u00a0H et\u00a0al (2008) Erythropoietic protoporphyria without skin symptoms-you do not always see what they feel. Eur J Pediatr 167:703\u2013706","journal-title":"Eur J Pediatr"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-024-05370-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-024-05370-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-024-05370-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T07:03:25Z","timestamp":1720076605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-024-05370-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,20]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["5370"],"URL":"https:\/\/doi.org\/10.1007\/s00105-024-05370-3","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"value":"2731-7005","type":"print"},{"value":"2731-7013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,20]]},"assertion":[{"value":"17 May 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"H.\u00a0Lindemann, E.\u00a0Diehl-Wiesenecker und L.\u00a0Gerischer geben keine Interessenkonflikte an. J.\u00a0Frank legt die folgenden potenziellen Interessenkonflikte offen: Er hat von den Firmen Genzyme und Shire Vortragshonorare und eine finanzielle Unterst\u00fctzung f\u00fcr den 2.\u00a0Weltkongresses f\u00fcr Genodermatologie im Jahr 2011 in Maastricht, Niederlande, erhalten. Er hat von den Firmen Roche, Bristol-Myers Squibb, Novartis, MSD und Orphan Europe Germany GmbH Vortragshonorare und finanzielle Unterst\u00fctzung zur Durchf\u00fchrung von Fortbildungsveranstaltungen erhalten. Dar\u00fcber hinaus hat er von der Firma Clinuvel eine Reisekostenunterst\u00fctzung zur Teilnahme am 23.\u00a0Weltkongress f\u00fcr Dermatologie in Vancouver, Kanada, erhalten und war als Studienleiter an 2\u00a0klinischen Studien der Phase\u00a02 und\u00a03 der Firma Clinuvel beteiligt. Er hat f\u00fcr die Organisation und Durchf\u00fchrung des Weltkongresses f\u00fcr Porphyrie-Erkrankungen 2015 (International Congress on Porphyrins and Porphyrias 2015) finanzielle Unterst\u00fctzung von den Firmen Alnylam Pharmaceuticals, Orphan Europe, Clinuvel Pharmaceuticals, La Roche-Posay und Lilly Deutschland GmbH erhalten. Ferner hat er von Alnylam Pharmaceuticals Honorare f\u00fcr die Teilnahme an Advisory Board-Veranstaltungen erhalten. Alle Autoren erkl\u00e4ren, dass sie sich bei der Erstellung des Beitrages nicht von wirtschaftlichen Interessen leiten lie\u00dfen.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}